Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Schlick

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
FEBS Letters|October 10, 2002
Eukaryotic initiation factor 4GI is a poor substrate for HIV-1 proteinasePetra Schlick, Tim Skern
Analytical Biochemistry|April 4, 2008
Investigating human immunodeficiency virus-1 proteinase specificity at positions P4 to P2 using a bacterial screening systemPetra Schlick, Tim Skern
The Biochemical Journal|April 20, 2002
Modulation of the electrostatic charge at the active site of foot-and-mouth-disease-virus leader proteinase, an unusual papain-like enzymePetra Schlick, Jakub Kronovetr, Bernhard Hampoelz, et al.
Journal of Virology|December 28, 2007
Functional analysis of potential carboxy-terminal cleavage sites of tick-borne encephalitis virus capsid proteinSabrina Schrauf, Petra Schlick, Tim Skern, et al.
Vaccine|July 6, 2010
Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutationsPetra Schlick, Regina M Kofler, Beate Schittl, et al.
Journal of Virology|March 20, 2009
Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virionsPetra Schlick, Christian Taucher, Beate Schittl, et al.
Vaccine|April 13, 2011
Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different agePetra Schmid, Sanja Selak, Michael Keller, et al.
Vaccine|March 31, 2011
The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in miceLidice Bernardo, Alequis Pavón, Lisset Hermida, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
FEBS Letters|October 10, 2002
Eukaryotic initiation factor 4GI is a poor substrate for HIV-1 proteinasePetra Schlick, Tim Skern
Analytical Biochemistry|April 4, 2008
Investigating human immunodeficiency virus-1 proteinase specificity at positions P4 to P2 using a bacterial screening systemPetra Schlick, Tim Skern
The Biochemical Journal|April 20, 2002
Modulation of the electrostatic charge at the active site of foot-and-mouth-disease-virus leader proteinase, an unusual papain-like enzymePetra Schlick, Jakub Kronovetr, Bernhard Hampoelz, et al.
Journal of Virology|December 28, 2007
Functional analysis of potential carboxy-terminal cleavage sites of tick-borne encephalitis virus capsid proteinSabrina Schrauf, Petra Schlick, Tim Skern, et al.
Vaccine|July 6, 2010
Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutationsPetra Schlick, Regina M Kofler, Beate Schittl, et al.
Journal of Virology|March 20, 2009
Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virionsPetra Schlick, Christian Taucher, Beate Schittl, et al.
Vaccine|April 13, 2011
Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different agePetra Schmid, Sanja Selak, Michael Keller, et al.
Vaccine|March 31, 2011
The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in miceLidice Bernardo, Alequis Pavón, Lisset Hermida, et al.
Pageof 1